"8"^^ . "6"^^ . "RIV/00216208:11120/14:43908242" . "RIV/00216208:11120/14:43908242!RIV15-MSM-11120___" . "Bioresorbable vascular scaffolds in acute ST-segment elevation myocardial infarction: a prospective multicentre study Prague 19"@en . . . "Bioresorbable vascular scaffolds (BVSs) have been studied in chronic coronary artery disease, but not in acute ST-segment elevation myocardial infarction (STEMI). This prospective multicentre study analysed the feasibility and safety of BVS implantation during primary percutaneous coronary intervention (p-PCI) in STEMI. Bioresorbable vascular scaffold implantation became the default strategy for all consecutive STEMI patients between 15 December 2012 and 30 August 2013. A total of 142 patients underwent p-PCI; 41 of them (28.9%) fulfilled the inclusion/exclusion criteria for BVS implantation. The BVS device success was 98%, thrombolysis in myocardial infarction 3 flow was restored in 95% of patients, and acute scaffold recoil was 9.7%. An optical coherence tomography (OCT) substudy (21 patients) demonstrated excellent procedural results with only a 1.1% rate of scaffold strut malapposition. Edge dissections were present in a 38% of patients, but were small and clinically silent. Reference vessel diameter measured by quantitative coronary angiography was significantly lower than that measured by OCT by 0.29 (\u00B10.56) mm, P = 0.028. Clinical outcomes were compared between BVS group and Control group; the latter was formed by patients who had implanted metallic stent and were in Killip Class I or II. Combined clinical endpoint was defined as death, myocardial infarction, or target vessel revascularization. Event-free survival was the same in both groups; 95% for BVS and 93% for Control group, P = 0.674. Conclusion Bioresorbable vascular scaffold implantation in acute STEMI is feasible and safe. The procedural results evaluated by angiography and OCT are excellent. The early clinical results are encouraging."@en . . "35" . . "Widimsk\u00FD, Petr" . "12" . "0195-668X" . . "Bud\u011B\u0161\u00EDnsk\u00FD, Tom\u00E1\u0161" . . . "11120" . "10.1093/eurheartj/eht545" . "GB - Spojen\u00E9 kr\u00E1lovstv\u00ED Velk\u00E9 Brit\u00E1nie a Severn\u00EDho Irska" . "Bioresorbable vascular scaffolds in acute ST-segment elevation myocardial infarction: a prospective multicentre study Prague 19"@en . . . "000334120600010" . "Prodanov, Petko" . . . . "Bioresorbable vascular scaffolds (BVSs) have been studied in chronic coronary artery disease, but not in acute ST-segment elevation myocardial infarction (STEMI). This prospective multicentre study analysed the feasibility and safety of BVS implantation during primary percutaneous coronary intervention (p-PCI) in STEMI. Bioresorbable vascular scaffold implantation became the default strategy for all consecutive STEMI patients between 15 December 2012 and 30 August 2013. A total of 142 patients underwent p-PCI; 41 of them (28.9%) fulfilled the inclusion/exclusion criteria for BVS implantation. The BVS device success was 98%, thrombolysis in myocardial infarction 3 flow was restored in 95% of patients, and acute scaffold recoil was 9.7%. An optical coherence tomography (OCT) substudy (21 patients) demonstrated excellent procedural results with only a 1.1% rate of scaffold strut malapposition. Edge dissections were present in a 38% of patients, but were small and clinically silent. Reference vessel diameter measured by quantitative coronary angiography was significantly lower than that measured by OCT by 0.29 (\u00B10.56) mm, P = 0.028. Clinical outcomes were compared between BVS group and Control group; the latter was formed by patients who had implanted metallic stent and were in Killip Class I or II. Combined clinical endpoint was defined as death, myocardial infarction, or target vessel revascularization. Event-free survival was the same in both groups; 95% for BVS and 93% for Control group, P = 0.674. Conclusion Bioresorbable vascular scaffold implantation in acute STEMI is feasible and safe. The procedural results evaluated by angiography and OCT are excellent. The early clinical results are encouraging." . "5481" . "Optical coherence tomography; Primary PCI; Acute myocardial infarction; Biodegradable stent; Bioresorbable vascular scaffold"@en . . "Lisa, Libor" . "Bioresorbable vascular scaffolds in acute ST-segment elevation myocardial infarction: a prospective multicentre study Prague 19" . "I" . . "Tou\u0161ek, Petr" . . . "Bioresorbable vascular scaffolds in acute ST-segment elevation myocardial infarction: a prospective multicentre study Prague 19" . . . "Ko\u010Dka, Viktor" . "European Heart Journal" . "8"^^ . "[3F053928A74D]" . . . .